title: Platelet and fibrin modification by radiographic contrast media.
abstract: The effect of the radiographic contrast agents, iopamidol and diatrizoate, on fibrin assembly and structure as well as platelet surface charge was studied. Increasing the iopamidol concentration from 0 to 4.5 mM prolongs the fibrin gelation time from 20 to 105 seconds (an anticoagulant effect) and reduces the fibrin fiber mass/length ratio from 3.2 x 10(12) to 0.5 x 10(12) Da/cm (i.e., produces very thin fibrin fibers). Ultraviolet difference spectroscopy of fibrinogen showed both a 15-nm shift in the ultraviolet difference maximum for iopamidol (suggesting binding) and a perturbation of the aromatic amino acid side chain region for fibrinogen (suggesting a conformational change in fibrinogen) as the concentration of iopamidol was increased from 0 to 9 mg/ml. Binding of iopamidol to fibrinogen was also shown by affinity chromatography using a Sepharose-fibrinogen column. Electrophoretic quasi elastic light scattering was used to show platelet interaction with iopamidol as reflected in a reduction in the platelet electrophoretic mobility from 2.0 to 0.5 (microns-cm)/(V-sec) as the concentration of iopamidol was increased from 0 to 4.5 mM. In addition, the ionic radiopaque contrast agent, Renografin, was also studied and found to inhibit fibrin monomer assembly. Although iopamidol is not shown to be thrombogenic, iopamidol does appear to reduce platelet surface charge, bind fibrinogen, and modify fibrin clot structure.
authors.affiliation: Department of Medicine, University of North Carolina at Chapel Hill 27599.
authors.forename: D A
authors.initials: DA
authors.lastname: Gabriel
authors.forename: M R
authors.initials: MR
authors.lastname: Jones
authors.forename: N S
authors.initials: NS
authors.lastname: Reece
authors.forename: E
authors.initials: E
authors.lastname: Boothroyd
authors.forename: T
authors.initials: T
authors.lastname: Bashore
mesh_terms: D001792:Blood Platelets / Q000187:drug effects*; D003287:Contrast Media / Q000494:pharmacology*; D003973:Diatrizoate / Q000494:pharmacology*; D004586:Electrophoresis; D005337:Fibrin / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D007479:Iopamidol / Q000494:pharmacology*; D008027:Light; D012542:Scattering, Radiation
chemical_list: D003287:Contrast Media; D003973:Diatrizoate; D005337:Fibrin; D007479:Iopamidol